Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
EMMA - EMMAUS LIFE SCIENCES INC NEW
Market Cap 11.80M P/E - EPS this Y - Ern Qtrly Grth -
Income -4.74M Forward P/E -3.14 EPS next Y - 50D Avg Chg -15.00%
Sales 28.46M PEG - EPS past 5Y - 200D Avg Chg -33.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -63.00%
Recommedations 2.00 Quick Ratio 0.10 Shares Outstanding 53.64M 52W Low Chg 210.00%
Insider Own 51.77% ROA 1.07% Shares Float 29.80M Beta 1.68
Inst Own 0.08% ROE - Shares Shorted/Prior 41.22K/33.64K Price 0.22
Gross Margin 93.69% Profit Margin -16.66% Avg. Volume 6,920 Target Price -
Oper. Margin 0.48% Earnings Date Aug 12 Volume 50 Change 0.00%
Healthcare | Biotechnology | United States
About EMMAUS LIFE SCIENCES INC NEW

Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally. The company's lead candidate is Endari, an L-glutamine oral powder to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older. It has a collaboration agreement with Kainos Medicine, Inc. for the preclinical development of Kainos' patented IRAK4 inhibitor (KM10544) as an anti-cancer drug. The company was formerly known as Emmaus Holdings, Inc. and changed its name to Emmaus Life Sciences, Inc. in September 2011. The company was founded in 2000 and is headquartered in Torrance, California.

EMMAUS LIFE SCIENCES INC NEW News
04/15/24 Emmaus Life Sciences Reports Delayed Filing of Annual Report
02/02/24 Emmaus Life Sciences Receives Marketing Authorization for Puerto Rico
11/14/23 Emmaus Life Sciences Reports Q3 2023 Financial Results
08/23/23 Emmaus Life Sciences Reports Management Changes
08/14/23 Emmaus Life Sciences Reports Q2 2023 Financial Results
07/13/23 Emmaus Life Sciences Receives Marketing Authorization for Endari® in Oman
05/31/23 Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA
EMMA Chatroom

User Image Ernestpoe Posted - 01/29/24

$EMMA bought a few shares along with TNBI. Go!

User Image risenhoover Posted - 12/20/23

$EMMA / Emmaus Life Sciences files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 15, 2023 Emmaus Life Sci https://fintel.io/doc/sec-emmaus-life-sciences-inc-822370-8k-2023-december-20-19711-9312?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image risenhoover Posted - 12/19/23

Insider Lim Seah H. reports buying 139,200 shares of $EMMA for a total cost of $30,916.00 https://fintel.io/n/us/emma/lim-seah-h?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=insider

User Image risenhoover Posted - 6 months ago

$EMMA / Emmaus Life Sciences Incorporation files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2023 Emmaus Life Sci https://fintel.io/doc/sec-emmaus-life-sciences-inc-822370-8k-2023-november-14-19675-6311?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image risenhoover Posted - 6 months ago

$EMMA / Emmaus Life Sciences Incorporation files form 10-Q https://fintel.io/doc/sec-emmaus-life-sciences-inc-822370-10q-2023-november-14-19675-8232?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image macroaxis Posted - 8 months ago

$QSI - Should I keep QuantumSi and Emmaus Life ( $EMMA ) in the same portfolio? Next fiscal quarter end is on 30th of September 2023 https://www.macroaxis.com/invest/pair-correlation/QSI/EMMA/QuantumSi-vs-Emmaus #portfolio_prospective #better_portfolio #diversify

User Image EarningsInsider Posted - 08/23/23

Emmaus Life Sciences, Inc. Files SEC Form 8-K $EMMA https://www.marketbeat.com/stocks/OTCMKTS/EMMA/sec-filings/

User Image risenhoover Posted - 08/23/23

$EMMA / Emmaus Life Sciences Incorporation files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 18, 2023 Emmaus Life Scien https://fintel.io/sf/us/emma?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image Stock_Titan Posted - 08/23/23

$EMMA Emmaus Life Sciences Reports Management Changes https://www.stocktitan.net/news/EMMA/emmaus-life-sciences-reports-management-vslpenln1q18.html

User Image STCKPRO Posted - 9 months ago

$EMMA NEW ARTICLE : Emmaus Life Sciences 2Q revenue surges as MENA sales climb https://www.stck.pro/news/EMMA/58874359/

User Image STCKPRO Posted - 9 months ago

$EMMA NEW ARTICLE : Emmaus Life Sciences Reports Q2 2023 Financial Results https://www.stck.pro/news/EMMA/58871879/

User Image EarningsInsider Posted - 9 months ago

Emmaus Life Sciences, Inc. Files SEC Form 8-K $EMMA https://www.marketbeat.com/stocks/OTCMKTS/EMMA/sec-filings/

User Image risenhoover Posted - 9 months ago

$EMMA / Emmaus Life Sciences Incorporation files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2023 Emmaus Life Scien https://fintel.io/sf/us/emma?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image EarningsInsider Posted - 9 months ago

Emmaus Life Sciences, Inc. Files SEC Form 10-Q $EMMA https://www.marketbeat.com/stocks/OTCMKTS/EMMA/sec-filings/

User Image risenhoover Posted - 9 months ago

$EMMA / Emmaus Life Sciences Incorporation files form 10-Q https://fintel.io/sf/us/emma?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image stockilluminati Posted - 9 months ago

$EMMA EMMA is scheduled to release earnings after close with EPS estimate -0.030600 and revenue estimate $0 check https://stockilluminati.com/earnings.html

User Image swingingtech Posted - 10 months ago

$EMMA https://wallstreetwaves.com/emmaus-life-sciences-receives-marketing-authorization-for-endari-in-oman/

User Image STCKPRO Posted - 10 months ago

$EMMA NEW ARTICLE : Emmaus Life Sciences Receives Marketing Authorization for Endari® in Oman https://www.stck.pro/news/EMMA/55949423/

User Image Stock_Titan Posted - 10 months ago

$EMMA Emmaus Life Sciences Receives Marketing Authorization for Endari® in Oman https://www.stocktitan.net/news/EMMA/emmaus-life-sciences-receives-marketing-authorization-for-endari-r-265kso17cr7z.html

User Image EarningsInsider Posted - 06/29/23

Emmaus Life Sciences Sees Short Interest Decrease from 12,900 shares to 4,500 shares. $EMMA https://www.marketbeat.com/stocks/OTCMKTS/EMMA/

User Image dividendinvestorbyeagle Posted - 11 months ago

$EMMA close decreased > 10% (Emmaus Life Sciences Inc (New)) https://www.dividendinvestor.com/dividend-news/?symbol=emma

User Image fla Posted - 11 months ago

$EMMA [15s. delayed] filed SEC form 4: COO LEE WILLIS C: Acquired 29,450 of Common stock at average price $0.29 between 2022-09-20 and 20 https://s.flashalert.me/2rSvA

User Image risenhoover Posted - 11 months ago

Insider Willis C Lee reports buying 29,450 shares of $EMMA for a total cost of $8,533.00 https://fintel.io/n/us/emma/lee-willis-c?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=insider

User Image dividendinvestorbyeagle Posted - 11 months ago

$EMMA close decreased > 10% (Emmaus Life Sciences Inc (New)) https://www.dividendinvestor.com/dividend-news/?symbol=emma

User Image dividendinvestorbyeagle Posted - 11 months ago

$EMMA close increased > 10% (Emmaus Life Sciences Inc (New)) https://www.dividendinvestor.com/dividend-news/?symbol=emma

User Image STCKPRO Posted - 05/31/23

$EMMA NEW ARTICLE : Emmaus Life Sciences receives approval to market Endari in Bahrain https://www.stck.pro/news/EMMA/51775970/

User Image STCKPRO Posted - 05/31/23

$EMMA NEW ARTICLE : Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA https://www.stck.pro/news/EMMA/51772696/

User Image fla Posted - 05/31/23

$EMMA [15s. delayed]: Issued Press Release on May 31, 14:11:00: Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bah https://s.flashalert.me/PprOg

User Image Stock_Titan Posted - 05/31/23

$EMMA Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA https://www.stocktitan.net/news/EMMA/emmaus-life-sciences-receives-endari-r-marketing-authorization-from-ojn5ifhshfzl.html

User Image dividendinvestorbyeagle Posted - 05/31/23

$EMMA close decreased > 10% (Emmaus Life Sciences Inc (New)) https://www.dividendinvestor.com/dividend-news/?symbol=emma

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Lim Seah H. Director Director Dec 20 Sell 0.05 32,500 1,625 4,586,626 12/21/23
Lim Seah H. Director Director Oct 09 Sell 0.11 6,000 660 171,700 12/19/23
Lim Seah H. Director Director Oct 09 Buy 0.17 139,200 23,664 177,700 12/19/23
LEE WILLIS C COO COO Aug 25 Buy 0.14 15,609 2,185 395,124 12/04/23
Niihara Yutaka Chairman and CEO Chairman and CEO Nov 03 Buy 0.41 52,600 21,566 12,040,857 12/01/22
Niihara Yutaka Chairman and CEO Chairman and CEO Oct 24 Buy 0.29 69,400 20,126 11,960,757 10/31/22
Niihara Yutaka Chairman and CEO Chairman and CEO Oct 19 Buy 0.18 65,000 11,700 11,891,357 10/24/22
Niihara Yutaka Chairman and CEO Chairman and CEO Oct 17 Buy 0.2 45,000 9,000 11,826,357 10/19/22
Niihara Yutaka Chairman and CEO Chairman and CEO Oct 13 Buy 0.18 97,500 17,550 11,781,357 10/17/22
LEE WILLIS C COO COO Jul 19 Buy 0.39 3,200 1,248 286,974 07/25/22
LEE WILLIS C Director & COO Director & COO May 27 Buy 0.39 5,000 1,950 283,774 06/03/22
Niihara Yutaka Chairman and CEO Chairman and CEO May 20 Buy 0.5 7,000 3,500 11,333,857 06/02/22
LEE WILLIS C Director & COO Director & COO Apr 04 Buy 0.89 15,100 13,439 278,774 04/12/22
Niihara Yutaka Chairman and CEO Chairman and CEO Feb 28 Buy 1.49 53,800 80,162 11,303,506 03/02/22
LEE WILLIS C Vice Chairman & COO Vice Chairman & COO Feb 22 Buy 1.5 21,100 31,650 1,900 02/28/22
Niihara Yutaka Chairman and CEO Chairman and CEO Feb 18 Buy 1.44 19,300 27,792 11,233,206 02/23/22
Niihara Yutaka Chairman and CEO Chairman and CEO Feb 16 Buy 1.45 7,500 10,875 11,213,906 02/18/22
Niihara Yutaka Chairman and CEO Chairman and CEO Feb 14 Buy 1.45 12,000 17,400 11,206,406 02/16/22
Niihara Yutaka Chairman and CEO Chairman and CEO Feb 09 Buy 1.46 30,500 44,530 11,194,406 02/11/22
Niihara Yutaka Chairman and CEO Chairman and CEO Feb 07 Buy 1.48 8,500 12,580 11,163,906 02/09/22
Niihara Yutaka Chairman and CEO Chairman and CEO Feb 03 Buy 1.42 13,250 18,815 11,155,406 02/07/22
LEE WILLIS C Vice Chairman & COO Vice Chairman & COO Nov 26 Buy 1.47 55,533 81,634 228,394 11/30/21